A detailed history of Clark Estates Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Clark Estates Inc holds 67,300 shares of HRMY stock, worth $2.29 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
67,300
Previous 60,000 12.17%
Holding current value
$2.29 Million
Previous $1.9 Million 2.22%
% of portfolio
0.56%
Previous 0.59%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$26.76 - $38.05 $195,348 - $277,765
7,300 Added 12.17%
67,300 $1.85 Million
Q1 2025

May 08, 2025

BUY
$32.18 - $40.46 $1.93 Million - $2.43 Million
60,000 New
60,000 $1.99 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.01B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Clark Estates Inc Portfolio

Follow Clark Estates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Clark Estates Inc with notifications on news.